Skip to main content

STRATA Skin Sciences, Inc.

SSKNDelisted Feb 19, 2026
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001051514

STRATA Skin Sciences, Inc. was delisted on Feb 19, 2026; its insiders filed their last Form 4 on Nov 18, 2025; 14 institutions reported holding it in 13F filings for Q4 2025, worth $1.37M in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
14
Q4 2025, −3 vs. previous quarter
13F value
$1.37M
Reported value at the end of Q4 2025
Superinvestors holding
0
At the end of Q4 2025

Superinvestors holding SSKN, Q4 2025

Go to the superinvestors tab

No superinvestor reported holding SSKN at the end of Q4 2025.

Latest insider trades

Open-market purchases and sales by STRATA Skin Sciences, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 18, 2025 (view filing)Nov 171 dayRubinstein SamuelDirectorSSale−14.1K$1.33−$18.8K−78.9%3.77K after3 lots
Nov 18, 2025 (view filing)Nov 18Same dayRubinstein SamuelDirectorPPurchase+5.00K$1.41+$7.03K+132.8%8.77K after2 lots
Jul 17, 2024 (view filing)5:08 PM ETJul 152 daysAccelmed Partners, L.P. and 3 others10% OwnerPPurchase+230.6K$3.14+$724.0K+19.0%1.44M afterDuplicate filing
Jul 17, 2024 (view filing)Jul 152 daysGeiger UriDirector, 10% OwnerPPurchase+230.6K$3.14+$724.0K+19.0%1.44M after
Jul 17, 2024 (view filing)Jul 152 daysRafaeli DolevChief Executive OfficerPPurchase+19.1K$3.14+$60.0K+15.4%143.2K after
Dec 5, 2023 (view filing)8:31 AM ETDec 14 daysGov ShmuelCOOPPurchaseSSKN Common Stock+20.0K$0.4478+$8.96KNew position20.0K after4 lots
Nov 20, 2023 (view filing)8:31 AM ETNov 164 daysRubinstein SamuelDirectorSSale−1.00K$0.32−$320−0.6%177.6K after
Aug 18, 2023 (view filing)4:34 PM ETAug 162 days22NW Fund, LP and 4 others10% OwnerPPurchase+1.85M$0.5521+$1.02M+52.7%5.37M after
Aug 11, 2023 (view filing)Aug 101 dayLesovitz ChristopherChief Financial OfficerPPurchaseSSKN Common Stock+15.2K$0.6734+$10.2K+65.5%38.3K after2 lots
Aug 11, 2023 (view filing)Aug 101 dayMoccia Robert JosephChief Executive OfficerPPurchaseSSKN Common Stock+42.0K$0.67+$28.1K+21.7%235.3K after

Top 10 13F holders, Q4 2025

The largest institutional positions in STRATA Skin Sciences, Inc. at the end of Q4 2025; share changes are against Q3 2025.

See all 14 holders
Institutions holding SSKN in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
22NW, LP536,995$676.6K0.52%00.0%Unchanged
Nantahala Capital Management, LLC403,917$508.9K0.03%00.0%Unchanged
Renaissance Technologies LLC63,830$80.4K0.00%−37,700−37.1%Reduced
Geode Capital Management, LLC18,896$23.8K0.00%+759+4.2%Added
Vanguard Group Inc16,375$20.6K0.00%−7,170−30.5%Reduced
Apollon Wealth Management, LLC15,105$19.0K0.00%+15,105New
Two Sigma Securities, LLC15,093$19.0K0.00%+15,093New
Creative Planning10,016$12.6K0.00%00.0%Unchanged
BlackRock, Inc.4,465$5.63K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,292$5.41K0.00%+2,463+134.7%Added

Holders of 5% or more of SSKN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of STRATA Skin Sciences, Inc..

See all 1 holders and filings
Largest holders of SSKN from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nantahala Capital Management, LLC13G/A9.68%403.9K shares–Nov 14, 20241 filingNov 14, 2024SEC